Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for Acute Hepatic Encephalopathy in Cirrhosis
NCT00886925Phase 4Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Mar 2009
- Primary completion
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of albumin (human) in hepatic encephalopathy (HE) (2 arms), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Proportion of patients without hepatic encephalopathy at Day 3. Started Mar 2009; status: completed.
02
Drugs
albumin (human)
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT00886925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00886925.